Wheatland Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-9,420
Closed -$605K 46
2019
Q4
$605K Sell
9,420
-7,980
-46% -$457K 0.77% 46
2019
Q3
$882K Sell
17,400
-11,000
-39% -$517K 0.8% 44
2019
Q2
$1.29M Hold
28,400
0.97% 35
2019
Q1
$1.35M Hold
28,400
1.03% 32
2018
Q4
$1.48M Hold
28,400
1.29% 27
2018
Q3
$1.76M Hold
28,400
1.33% 25
2018
Q2
$1.57M Hold
28,400
1.27% 26
2018
Q1
$1.8M Hold
28,400
1.48% 22
2017
Q4
$1.74M Hold
28,400
1.41% 23
2017
Q3
$1.81M Hold
28,400
1.55% 23
2017
Q2
$1.58M Sell
28,400
-1,300
-4% -$70.7K 1.43% 24
2017
Q1
$1.61M Sell
29,700
-1,300
-4% -$71.3K 1.44% 23
2016
Q4
$1.81M Hold
31,000
1.61% 23
2016
Q3
$1.67M Buy
31,000
+100
+0.3% +$6.42K 1.57% 24
2016
Q2
$2.27M Sell
30,900
-800
-3% -$56.5K 2.18% 16
2016
Q1
$2.02M Hold
31,700
2.07% 18
2015
Q4
$2.18M Hold
31,700
2.23% 15
2015
Q3
$1.88M Hold
31,700
2.04% 17
2015
Q2
$2.11M Hold
31,700
2.03% 17
2015
Q1
$2.04M Buy
31,700
+50
+0.2% +$3.13K 2.04% 18
2014
Q4
$1.87M Sell
31,650
-800
-2% -$45.1K 1.82% 21
2014
Q3
$1.66M Hold
32,450
1.66% 23
2014
Q2
$1.57M Hold
32,450
1.43% 29
2014
Q1
$1.69M Hold
32,450
1.72% 23
2013
Q4
$1.73M Buy
+32,450
New +$1.65M 1.81% 22

Other funds holding BMY

Wheatland Advisors's BMY Position: Q1 2020 in Review

Wheatland Advisors sold out of Bristol-Myers Squibb (BMY) in Q1 2020, closing a stake of 9,420 shares — an estimated $605K sold.

Wheatland Advisors first reported a position in BMY in Q4 2013 and held it in 25 quarters. The position peaked at $2.27M in Q2 2016. 2,148 funds tracked by Wall St. Rank hold BMY as of Q1 2020.

  • Wheatland Advisors reported no remaining Bristol-Myers Squibb position as of Q1 2020 after selling out during the quarter.
  • Wheatland Advisors sold 9,420 Bristol-Myers Squibb shares in Q1 2020, an estimated $605K.
  • Wheatland Advisors first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 25 quarters.
  • Wheatland Advisors's Bristol-Myers Squibb position peaked at $2.27M in Q2 2016.
  • 2,148 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2020.

Based on Wheatland Advisors's 13F filing for Q1 2020, filed 8 May 2020.